# PROLACTA BIOSCIENCE INC: Form D filings

PROLACTA BIOSCIENCE INC, a biotechnology company in Duarte, CA, filed 4 Form D notices with the SEC between 2011 and 2018. The latest, on May 14, 2018, reports $8.9 million sold of a $8.9 million offering to 11 investors.

Find out what PROLACTA BIOSCIENCE INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20PROLACTA%20BIOSCIENCE%20INC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=PROLACTA%20BIOSCIENCE%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fprolacta-bioscience-inc-1294955)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20PROLACTA%20BIOSCIENCE%20INC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=PROLACTA%20BIOSCIENCE%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fprolacta-bioscience-inc-1294955)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in California](https://specstream.ai/data/form-d/state/california): 5,891 rows, by operating companies, filed since November 1, 2024, $138.91, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/california
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 1800 Highland Ave, Duarte, CA, 91010
- Phone: (626) 599-9260
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1294955

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| May 14, 2018 | New notice | $8,908,625 | $8,908,625 | $0 | 11 | May 10, 2018 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1294955/000129495518000001/0001294955-18-000001-index.htm) |
| Dec 9, 2016 | New notice | $34,999,997 | $34,999,997 | $0 | 4 | Nov 29, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1294955/000129495516000002/0001294955-16-000002-index.htm) |
| Nov 2, 2011 | New notice | $15,000,000 | $15,000,000 | $0 | 2 | Oct 27, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1294955/000129495511000005/0001294955-11-000005-index.htm) |
| Aug 9, 2011 | New notice | $5,783,892 | $5,783,892 | $0 | 20 | Jun 17, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1294955/000129495511000004/0001294955-11-000004-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| John Shields | Executive Officer |  |
| David Brailer | Director |  |
| Mark Hannon | Executive Officer |  |
| Victoria Niklas | Executive Officer |  |
| Ernie Strapazon | Director |  |
| Frank Foster | Director |  |
| John Bacich Jr. | Director |  |
| David Dreyer | Executive Officer |  |
| Vincent Gaspar | Executive Officer |  |
| Alan Kofsky | Executive Officer |  |
| Martin Sutter | Director |  |
| Scott Eaker | Executive Officer |  |
| Scott Elster | Executive Officer, Director |  |
| Joseph Fournell | Executive Officer |  |
| Martin Lee | Executive Officer |  |
| Dan Janney | Director |  |
| Sally Crawford | Director |  |
| Alyson Fuller | Executive Officer |  |

## Other biotechnology companies in California that filed recently

- [CARI Health, Inc.](https://specstream.ai/data/form-d/company/cari-health-inc-1930994) $280,000 · Nov 6, 2026
- [Ausel, Inc.](https://specstream.ai/data/form-d/company/ausel-inc-2124022) $120,000 · Nov 4, 2026
- [Trellis Bioscience, Inc.](https://specstream.ai/data/form-d/company/trellis-bioscience-inc-1162015) $9.1 million · Oct 29, 2026
- [BigHat Biosciences, Inc.](https://specstream.ai/data/form-d/company/bighat-biosciences-inc-1797256) $75.1 million · Oct 26, 2026
- [Theravie Pharma, Inc.](https://specstream.ai/data/form-d/company/theravie-pharma-inc-2160768) $750,000 · Oct 19, 2026
- [Adela, Inc.](https://specstream.ai/data/form-d/company/adela-inc-1852167) $12 million · Oct 19, 2026

[Every Form D from the week of May 14, 2018](https://specstream.ai/data/form-d/week/2018-05-14) · [All recent filings in California](https://specstream.ai/data/form-d/state/california) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what PROLACTA BIOSCIENCE INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).